Please enable JavaScript to continue using this application.

Compare tickers

Valuation, margins, and growth side by side.

Compare $CTSO vs $NMTC | Chartloom

Compare

$CTSO vs $NMTC

Cytosorbents Corp · NeuroOne Medical Technologies Corp

CTSO

Cytosorbents Corp

NMTC

NeuroOne Medical Technologies Corp

Compare $CTSO vs $NMTC

Comparing Cytosorbents Corp and NeuroOne Medical Technologies Corp

CTSOCytosorbents Corp

NMTCNeuroOne Medical Technologies Corp

CTSOCytosorbents Corp

Market cap

$217M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

5.02x

Rev growth (TTM)

8.6%

YTD performance

-73.6%

52W performance

-81.1%

FCF yield

-4.5%

NMTCNeuroOne Medical Technologies Corp

Market cap

$10M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

0.76x

Rev growth (TTM)

3.8%

YTD performance

-78.5%

52W performance

-80.7%

FCF yield

-74.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CTSO

NMTC

Detailed metrics comparison

CTSO

Cytosorbents Corp

NMTC

NeuroOne Medical Technologies Corp

Market Cap

CTSO$217M

NMTC$10M

Enterprise Value

CTSO$230M

NMTC$8M

Price

CTSO$3.46

NMTC$1.10

P/E Ratio

CTSON/A

NMTCN/A

P/S Ratio

CTSO5.84x

NMTC0.96x

EV/Sales

CTSO6.19x

NMTC0.75x

EV/EBITDA

CTSO0.00x

NMTC0.00x

P/B Ratio

CTSO5.44x

NMTC2.71x

P/FCF Ratio

CTSON/A

NMTCN/A

EV/FCF

CTSO-23.75x

NMTC-1.05x

PEG Ratio

CTSON/A

NMTCN/A

Forward P/E (NTM)

CTSON/A

NMTCN/A

Forward P/S (NTM)

CTSO5.02x

NMTC0.76x

Revenue (TTM)

CTSO$37M

NMTC$10M

Revenue Growth (YoY)

CTSO8.6%

NMTC3.8%

Forward Rev Growth

CTSO13.6%

NMTC57.3%

Gross Margin (TTM)

CTSO71.6%

NMTC55.7%

Operating Margin (TTM)

CTSO0.0%

NMTC0.0%

EBITDA Margin (TTM)

CTSO-28.3%

NMTC-73.7%

Net Margin (TTM)

CTSO-48.9%

NMTC-71.5%

FCF Margin (TTM)

CTSO-26.0%

NMTC-71.6%

Net Income (TTM)

CTSO$-18M

NMTC$-7M

FCF (TTM)

CTSO$-10M

NMTC$-7M

EPS (TTM)

CTSO-$0.29

NMTC-$0.83

ROE (TTM)

CTSO-16513.0%

NMTC-12645.0%

ROA (TTM)

CTSO-4325.0%

NMTC-8558.0%

ROIC (TTM)

CTSO-5193.0%

NMTC-12645.0%

Cash

CTSO$4M

NMTC$2M

Debt

CTSO$17M

NMTC$0

Net Cash/Debt

CTSO$-13M

NMTC$2M

Current Ratio (TTM)

CTSO0.66x

NMTC2.84x

Quick Ratio (TTM)

CTSO0.47x

NMTC1.56x

Debt/Equity (TTM)

CTSO7.73x

NMTC0.00x

Debt/Assets (TTM)

CTSO0.0%

NMTC0.0%

Interest Coverage (TTM)

CTSON/A

NMTCN/A

Net Debt/EBITDA (TTM)

CTSO0.00x

NMTC0.00x

Beta

CTSO1.51

NMTC0.92

52W Performance

CTSO-81.1%

NMTC-80.7%

YTD Performance

CTSO-73.6%

NMTC-78.5%

% from 52W High

CTSO-82.5%

NMTC-82.0%

% from 52W Low

CTSO1.1%

NMTC14.4%

Asset Turnover (TTM)

CTSO0.88x

NMTC1.20x

FCF Yield (TTM)

CTSO-4.5%

NMTC-74.8%

Earnings Yield (TTM)

CTSO-8.4%

NMTC-74.7%

Dividend Yield (TTM)

CTSON/A

NMTCN/A

Rule of 40

CTSO-17.4

NMTC-67.8

EV/GP/RG

CTSO0.53

NMTC0.05

Ticker research

View CTSO research View NMTC research

Metric	CTSO Cytosorbents Corp	NMTC NeuroOne Medical Technologies Corp
Market & Valuation
Market Cap	$217M	$10M
Enterprise Value	$230M	$8M
Price	$3.46	$1.10
P/E Ratio	N/A	N/A
P/S Ratio	5.84x	0.96x
EV/Sales	6.19x	0.75x
EV/EBITDA	0.00x	0.00x
P/B Ratio	5.44x	2.71x
P/FCF Ratio	N/A	N/A
EV/FCF	-23.75x	-1.05x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	5.02x	0.76x
Revenue & Growth
Revenue (TTM)	$37M	$10M
Revenue Growth (YoY)	8.6%	3.8%
Forward Rev Growth	13.6%	57.3%
Profitability
Gross Margin (TTM)	71.6%	55.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-28.3%	-73.7%
Net Margin (TTM)	-48.9%	-71.5%
FCF Margin (TTM)	-26.0%	-71.6%
Net Income (TTM)	$-18M	$-7M
FCF (TTM)	$-10M	$-7M
EPS (TTM)	-$0.29	-$0.83
ROE (TTM)	-16513.0%	-12645.0%
ROA (TTM)	-4325.0%	-8558.0%
ROIC (TTM)	-5193.0%	-12645.0%
Financial Health
Cash	$4M	$2M
Debt	$17M	$0
Net Cash/Debt	$-13M	$2M
Current Ratio (TTM)	0.66x	2.84x
Quick Ratio (TTM)	0.47x	1.56x
Debt/Equity (TTM)	7.73x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.51	0.92
52W Performance	-81.1%	-80.7%
YTD Performance	-73.6%	-78.5%
% from 52W High	-82.5%	-82.0%
% from 52W Low	1.1%	14.4%
Efficiency & Yields
Asset Turnover (TTM)	0.88x	1.20x
FCF Yield (TTM)	-4.5%	-74.8%
Earnings Yield (TTM)	-8.4%	-74.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-17.4	-67.8
EV/GP/RG	0.53	0.05
Ticker research	View CTSO research	View NMTC research

Valuation

P/S Ratio

NMTC

0.96x

CTSO

5.84x

EV/FCF

CTSO

-23.75x

NMTC

-1.05x

Growth & revenue

Revenue Growth TTM

CTSO

8.6%

NMTC

3.8%

Forward Revenue Growth

NMTC

57.3%

CTSO

13.6%

Profitability & performance

Gross Margin

CTSO

71.6%

NMTC

55.7%

ROE

NMTC

-12645.0%

CTSO

-16513.0%

FCF Yield %

CTSO

-4.5%

NMTC

-74.8%

52-Week Performance

NMTC

-80.7%

CTSO

-81.1%

Detailed metrics comparison

CTSO

Cytosorbents Corp

NMTC

NeuroOne Medical Technologies Corp

Market Cap

CTSO$217M

NMTC$10M

Enterprise Value

CTSO$230M

NMTC$8M

Price

CTSO$3.46

NMTC$1.10

P/E Ratio

CTSON/A

NMTCN/A

P/S Ratio

CTSO5.84x

NMTC0.96x

EV/Sales

CTSO6.19x

NMTC0.75x

EV/EBITDA

CTSO0.00x

NMTC0.00x

P/B Ratio

CTSO5.44x

NMTC2.71x

P/FCF Ratio

CTSON/A

NMTCN/A

EV/FCF

CTSO-23.75x

NMTC-1.05x

PEG Ratio

CTSON/A

NMTCN/A

Forward P/E (NTM)

CTSON/A

NMTCN/A

Forward P/S (NTM)

CTSO5.02x

NMTC0.76x

Revenue (TTM)

CTSO$37M

NMTC$10M

Revenue Growth (YoY)

CTSO8.6%

NMTC3.8%

Forward Rev Growth

CTSO13.6%

NMTC57.3%

Gross Margin (TTM)

CTSO71.6%

NMTC55.7%

Operating Margin (TTM)

CTSO0.0%

NMTC0.0%

EBITDA Margin (TTM)

CTSO-28.3%

NMTC-73.7%

Net Margin (TTM)

CTSO-48.9%

NMTC-71.5%

FCF Margin (TTM)

CTSO-26.0%

NMTC-71.6%

Net Income (TTM)

CTSO$-18M

NMTC$-7M

FCF (TTM)

CTSO$-10M

NMTC$-7M

EPS (TTM)

CTSO-$0.29

NMTC-$0.83

ROE (TTM)

CTSO-16513.0%

NMTC-12645.0%

ROA (TTM)

CTSO-4325.0%

NMTC-8558.0%

ROIC (TTM)

CTSO-5193.0%

NMTC-12645.0%

Cash

CTSO$4M

NMTC$2M

Debt

CTSO$17M

NMTC$0

Net Cash/Debt

CTSO$-13M

NMTC$2M

Current Ratio (TTM)

CTSO0.66x

NMTC2.84x

Quick Ratio (TTM)

CTSO0.47x

NMTC1.56x

Debt/Equity (TTM)

CTSO7.73x

NMTC0.00x

Debt/Assets (TTM)

CTSO0.0%

NMTC0.0%

Interest Coverage (TTM)

CTSON/A

NMTCN/A

Net Debt/EBITDA (TTM)

CTSO0.00x

NMTC0.00x

Beta

CTSO1.51

NMTC0.92

52W Performance

CTSO-81.1%

NMTC-80.7%

YTD Performance

CTSO-73.6%

NMTC-78.5%

% from 52W High

CTSO-82.5%

NMTC-82.0%

% from 52W Low

CTSO1.1%

NMTC14.4%

Asset Turnover (TTM)

CTSO0.88x

NMTC1.20x

FCF Yield (TTM)

CTSO-4.5%

NMTC-74.8%

Earnings Yield (TTM)

CTSO-8.4%

NMTC-74.7%

Dividend Yield (TTM)

CTSON/A

NMTCN/A

Rule of 40

CTSO-17.4

NMTC-67.8

EV/GP/RG

CTSO0.53

NMTC0.05

Ticker research

View CTSO research View NMTC research

Metric	CTSO Cytosorbents Corp	NMTC NeuroOne Medical Technologies Corp
Market & Valuation
Market Cap	$217M	$10M
Enterprise Value	$230M	$8M
Price	$3.46	$1.10
P/E Ratio	N/A	N/A
P/S Ratio	5.84x	0.96x
EV/Sales	6.19x	0.75x
EV/EBITDA	0.00x	0.00x
P/B Ratio	5.44x	2.71x
P/FCF Ratio	N/A	N/A
EV/FCF	-23.75x	-1.05x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	5.02x	0.76x
Revenue & Growth
Revenue (TTM)	$37M	$10M
Revenue Growth (YoY)	8.6%	3.8%
Forward Rev Growth	13.6%	57.3%
Profitability
Gross Margin (TTM)	71.6%	55.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-28.3%	-73.7%
Net Margin (TTM)	-48.9%	-71.5%
FCF Margin (TTM)	-26.0%	-71.6%
Net Income (TTM)	$-18M	$-7M
FCF (TTM)	$-10M	$-7M
EPS (TTM)	-$0.29	-$0.83
ROE (TTM)	-16513.0%	-12645.0%
ROA (TTM)	-4325.0%	-8558.0%
ROIC (TTM)	-5193.0%	-12645.0%
Financial Health
Cash	$4M	$2M
Debt	$17M	$0
Net Cash/Debt	$-13M	$2M
Current Ratio (TTM)	0.66x	2.84x
Quick Ratio (TTM)	0.47x	1.56x
Debt/Equity (TTM)	7.73x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.51	0.92
52W Performance	-81.1%	-80.7%
YTD Performance	-73.6%	-78.5%
% from 52W High	-82.5%	-82.0%
% from 52W Low	1.1%	14.4%
Efficiency & Yields
Asset Turnover (TTM)	0.88x	1.20x
FCF Yield (TTM)	-4.5%	-74.8%
Earnings Yield (TTM)	-8.4%	-74.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-17.4	-67.8
EV/GP/RG	0.53	0.05
Ticker research	View CTSO research	View NMTC research